Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Orr Shomroni
    Member
    • Oct 2011
    • 26

    #1

    Enrichment of disease ontology enrichment

    I have recently come across a R package that allows users to check for genes in the disease ontology (DO.db), and I thought it might be interesting to run an enrichment test on this ontology.

    Currently, I have come across 2 R packages that support this option:
    (1) GeneAnswers package
    (2) DOSE package

    Apperently, GeneAnswers allows the usage of DOLite (a more condensced ontology renaming categories as groups) but not the usage of DO, and DOSE enrichment command allows both options. Furthermore, it seems both DOSE and GeneAnswers are using hypergeometric tests. Nevertheless, when I run both commands for DOLite with the same p-adjustment method (FDR/Benjamini) and same p-value threshold (0.05) for the same genes, I am getting quite a difference in results.

    My questions are:
    (1) Is anyone here familiar with GeneAnswers and DOSE packages enough to know how they differ technically?
    (2) Is any of the 2 packages considered generally better than the other?
    (3) Are there any other good tools (in any programming language) that can be used to analyse the enrichment of disease ontology from gene names?
    "Though it may seem that all's been said and done, originality still lives on" - some unoriginal guy who had nothing better to write as his signature
  • ygc_hku
    Junior Member
    • Nov 2014
    • 6

    #2
    please refer to : http://bioinformatics.oxfordjournals...bstract/btu684

    DOSE supports DOLite (which was not updated) and DO (recently updated) with hypergeometric test and Gene Set Enrichment Analysis.

    Comment

    • ygc_hku
      Junior Member
      • Nov 2014
      • 6

      #3
      For comparing GeneAnswers and DOSE (internal algorithm is same as in clusterProfiler), please refer to: http://ygc.name/2014/08/07/why-clusterprofiler-fails/



      Originally posted by Orr Shomroni View Post
      I have recently come across a R package that allows users to check for genes in the disease ontology (DO.db), and I thought it might be interesting to run an enrichment test on this ontology.

      Currently, I have come across 2 R packages that support this option:
      (1) GeneAnswers package
      (2) DOSE package

      Apperently, GeneAnswers allows the usage of DOLite (a more condensced ontology renaming categories as groups) but not the usage of DO, and DOSE enrichment command allows both options. Furthermore, it seems both DOSE and GeneAnswers are using hypergeometric tests. Nevertheless, when I run both commands for DOLite with the same p-adjustment method (FDR/Benjamini) and same p-value threshold (0.05) for the same genes, I am getting quite a difference in results.

      My questions are:
      (1) Is anyone here familiar with GeneAnswers and DOSE packages enough to know how they differ technically?
      (2) Is any of the 2 packages considered generally better than the other?
      (3) Are there any other good tools (in any programming language) that can be used to analyse the enrichment of disease ontology from gene names?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
        by SEQadmin2




        NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
        Today, 06:46 AM
      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-28-2026, 09:57 AM
      0 responses
      24 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-28-2026, 09:51 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      68 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...